We are pleased to announce our newly designed Gnoto-safe® Shipping (GSS) container, which combines the latest in animal welfare and colony management in an environmentally responsible way. Beginning Sunday, September 4, 2016, all VAF/Elite® and immunodeficient animal models ordered through Charles River will be shipped to you in this new container.
Charles River has established ICH core battery tests and supplementary safety pharmacology models to meet current regulatory requirements. In an effort to further support our partners' needs, Charles River is continually validating state-of-the-art equipment, assays and experimental techniques to improve both current evaluations and animal welfare.
Charles River Pre-ID™ services offer multiple identification options, including ear tag, microchip implant, ear notch and tattooing. In the coming months, we will be introducing the Labstamp® method in Europe, which involves a mouse tail tattoo process that is automated, permanent and visual at the cage level.
We’ve moved our Avian Vaccine Services office headquarters from North Franklin, CT to neighboring Norwich, CT. We look forward to serving our many loyal customers at our new site.
Ferrets (Mustela putorius) and cotton rats (Sigmodon hispidus) are the primary animals used in vaccine development for infectious respiratory diseases such as influenza, RSV and hMPV. The availability of these and other suitable animal models is an essential component in the development and final lot release of many other human and veterinary infectious disease vaccines.
The Charles River Biologics Testing Division has begun its implementation of a laboratory execution system (LES) throughout its global sites. LES is a computer program designed to replace paper laboratory notebooks, increase accuracy and efficiency, and streamline the review of daily laboratory activities.
Explore our recently expanded Safety Assessment portfolio with ease. Our new navigation structure uses drop-down and fly-out menus to give you quicker access to information.
We are excited to announce the addition of Blue Stream Laboratories to our growing Charles River team. The expertise of the Blue Stream organization will enhance our analytical capabilities, providing you with a complete solution for your biologic and biosimilar development.
As a result of Charles River’s continued commitment to emerging drug discovery technologies, a strategic collaboration has been established with caprotec bioanalytics, GmbH, to offer their proprietary protein capture technology for phenotypic screening target deconvolution.
During the finalization of the OECD 443 guideline, Extended One-generation Reproductive Toxicity Study (EOGRTS), scientists at our facilities in Den Bosch, Lyon and Ashland were asked to work on the implementation of this study type and to harmonize the study designs at the sites.